Several studies have shown that MRGBP expression was increased in most cancer cell lines such as PDAC cell lines and the proliferative, migratory and invasive capacities of ASPC-1 and Mia PaCa-2 were significantly reduced (Ding et al., 2017). This evidence concerns the gene MRGBP and cancer.